Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Access Biotechnology
company
About
Access Biotechnology is an investment arm of Access Industries that focuses on private and public biopharma companies.
- 1 - 10
Highlights
Details
- Industries
- Biopharma,Biotechnology,Health Care,Life Science
- Founded date
- Jan 1, 1986
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Investor Type
- CVC
Access Biotechnology is the life science investment arm of Access Industries. They invest in transformative therapies for conditions with high unmet needs and that have the potential to meaningfully impact human health. They invest in both private and public biopharma companies across therapeutic areas, modalities, and development stages – from discovery-stage technology platforms to late-stage clinical programs.The company is based in New York.
Investments
Number of Investments
Number of Lead Investments
3
0
Access Biotechnology has made 3 investments. Their most recent investment was on
Sep 12, 2022, when Nimbus Therapeutics raised $125M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Sep 12, 2022
Nimbus Therapeutics
|
Series Unknown | $125M | Biotechnology | — |
|
Jul 12, 2022
Areteia Therapeutics
|
Series A | $350M | Biotechnology | — |
|
Jul 13, 2021
Nimbus Therapeutics
|
Series Unknown | $105M | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
